Why the study?
Moderate hypothermic circulatory arrest is widely used in aortic arch surgery, but its effect on postoperative renal function compared with deep hypothermic circulatory arrest remains controversial.
Does moderate hypothermic circulatory arrest reduce renal failure in patients undergoing aortic arch surgery compared to deep hypothermic circulatory arrest?
Does moderate hypothermic circulatory arrest reduce renal failure in patients undergoing aortic arch surgery compared to deep hypothermic circulatory arrest?
Moderate hypothermic circulatory arrest reduces the incidence of postoperative renal failure and the need for renal replacement therapy compared to deep hypothermic circulatory arrest in aortic arch surgery.
Answers are grounded in this paper and cite their sources.
May favor MHCA over DHCA to reduce renal morbidity in aortic arch surgery; strengthens evidence amid mixed prior findings.
Background Moderate hypothermic circulatory arrest (MHCA) has been widely used in aortic arch surgery. However, the renal function after MHCA remains controversial. We performed a systematic review and meta-analysis direct comparison of the postoperative renal function of MHCA versus deep hypothermic circulatory arrest (DHCA) in aortic arch surgery. Methods and Results We searched PubMed, Embase, and the Cochrane Library for postoperative renal function after aortic arch surgery with using MHCA and DHCA, published from inception to January 31, 2020. The primary outcome was renal failure. Secondary outcomes were the need for renal therapy and other major postoperative outcomes. The random-effects model was used for all comparisons to pool the estimates. A total of 14 observational studies with 4142 patients were included. Compared with DHCA, MHCA significantly reduced the incidence of renal failure (odds ratio [OR], 0.76; 95% CI, 0.61-0.94; P=0.011; I²=0.0%) and the need of renal replacement (OR, 0.68; 95% CI, 0.48-0.97; P=0.034; I²=0.0%). Subgroup analysis showed that when the hypothermic circulatory arrest time was <30 minutes, the incidence of renal failure in MHCA group was significantly lower than that in DHCA group (OR, 0.73; 95% CI, 0.54-0.99; P=0.040; I²=1.1%), whereas an insignificant difference between 2 groups when hypothermic circulatory arrest time was >30 minutes (OR, 0.76; 95% CI, 0.51-1.13; P=0.169; I²=17.3%). Conclusions MHCA compared with DHCA reduces the incidence of renal failure and the need for renal replacement. Registration URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42020169348.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: